Current Gene Therapy
Title:Gene Therapy for Neuroprotection and Neurorestoration (Part I)
Volume: 19 Issue: 6
Author(s): Ghulam Md. Ashraf and Md. Sahab Uddin
Affiliation:
Export Options
About this article
Cite this article as:
Ashraf Md. Ghulam and Uddin Sahab Md. , Gene Therapy for Neuroprotection and Neurorestoration (Part I), Current Gene Therapy 2019; 19 (6) . https://dx.doi.org/10.2174/156652321906200324121208
DOI https://dx.doi.org/10.2174/156652321906200324121208 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Heart Valve Lesions In The Antiphospholipid Syndrome
Current Rheumatology Reviews Retigabine: Could it be the Next Broad-Spectrum Antiepileptic Drug?
Current Drug Therapy Pharmacological Tools to Activate Microglia and their Possible use to Study Neural Network Patho-physiology
Current Neuropharmacology Rab GTPases, Membrane Trafficking and Diseases
Current Drug Targets Tuning and Fine-Tuning of Synapses with Adenosine
Current Neuropharmacology Allele Frequency Distributions of the Drug Metabolizer Genes <i>CYP2C9*2</i>, <i>CYP2C9*3</i>, and <i>CYP2C19*17</i> in the Buginese Population of Indonesia
Current Pharmacogenomics and Personalized Medicine Antitumor Potential and Possible Targets of Phenothiazine-Related Compounds
Current Drug Targets Exosomes: Natural Carriers for siRNA Delivery
Current Pharmaceutical Design Analysis of Electrical Brain Waves in Neurotoxicology: Gamma- Hydroxybutyrate
Current Neuropharmacology A Novel Efficient Machine Learning Approach for Multiclass Classification of EEG Signal
Recent Patents on Computer Science The Effects of Hydroalcoholic Extract of Pinus eldarica on Hippocampal Tissue Oxidative Damage in Pentylenetetrazole-Induced Seizures in Rat
Current Nutrition & Food Science Neuropharmacology of Cannabinoid System: From Basic Science to Clinical Applications
Current Neuropharmacology New Anticonvulsant Agents
Current Topics in Medicinal Chemistry PDZ Domain-mediated Protein Interactions: Therapeutic Targets in Neurological Disorders
Current Medicinal Chemistry 5 Hz Repetitive Transcranial Magnetic Stimulation with Maximum Voluntary Muscle Contraction Facilitates Cerebral Cortex Excitability of Normal Subjects
CNS & Neurological Disorders - Drug Targets A Review on Possible Therapeutic Effect of Nigella sativa and Thymoquinone in Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Mechanisms of Neuronal Injury and Death in HIV-1 Associated Dementia
Current HIV Research Metabotropic Glutamate Receptor Ligands as Potential Therapeutics for Addiction
Current Drug Abuse Reviews Mutations of mtDNA in some Vascular and Metabolic Diseases
Current Pharmaceutical Design Renin-Angiotensin System in Central Nervous System Diseases and its Interaction with COVID-19
Current Medicinal Chemistry